Eris Lifesciences Limited

Eris Lifesciences Limited (ERIS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

eris.co.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹1303.50
Market cap
18,063 Cr
Stock P/E
28.2
P/B
4.57
Dividend yield
0.6%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales505 Cr486 Cr551 Cr720 Cr739 Cr727 Cr705 Cr773 Cr792 Cr807 Cr757 Cr873 Cr
Operating expenses (approx.)324 Cr311 Cr402 Cr470 Cr477 Cr477 Cr453 Cr496 Cr504 Cr526 Cr483 Cr577 Cr
EBITDA181 Cr176 Cr148 Cr250 Cr262 Cr250 Cr252 Cr277 Cr288 Cr282 Cr274 Cr296 Cr
OPM %35.8%36.1%26.9%34.7%35.5%34.4%35.8%35.8%36.4%34.9%36.2%33.9%
Other income3 Cr4 Cr15 Cr2 Cr7 Cr4 Cr8 Cr3 Cr3 Cr0.02 Cr2 Cr2 Cr
Interest16 Cr18 Cr33 Cr60 Cr59 Cr57 Cr54 Cr49 Cr50 Cr49 Cr46 Cr47 Cr
Depreciation42 Cr46 Cr54 Cr76 Cr80 Cr81 Cr77 Cr71 Cr69 Cr70 Cr70 Cr72 Cr
Profit before tax126 Cr116 Cr77 Cr115 Cr129 Cr116 Cr129 Cr161 Cr173 Cr145 Cr159 Cr179 Cr
Tax %3.1%12.4%-3.9%22.5%25.4%25.2%20.6%22.3%22.1%25.1%-75.1%20.2%
Net profit122 Cr101 Cr80 Cr89 Cr96 Cr87 Cr102 Cr125 Cr134 Cr109 Cr279 Cr143 Cr
EPS (₹)₹9.08₹7.55₹5.22₹6.11₹6.73₹6.15₹6.90₹8.66₹8.82₹7.32₹20.60₹10.28

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales982 Cr1,074 Cr1,212 Cr1,347 Cr1,685 Cr2,009 Cr2,894 Cr3,129 CrSign in for TTM
Operating expenses (approx.)637 Cr706 Cr781 Cr862 Cr1,148 Cr1,334 Cr1,876 Cr2,009 CrSign in for TTM
EBITDA345 Cr368 Cr431 Cr485 Cr537 Cr675 Cr1,017 Cr1,120 CrSign in for TTM
OPM %35.1%34.3%35.5%36.0%31.9%33.6%35.2%35.8%Sign in for TTM
Other income32 Cr15 Cr9 Cr26 Cr11 Cr24 Cr18 Cr8 CrSign in for TTM
Interest23 Cr2 Cr2 Cr4 Cr26 Cr85 Cr231 Cr193 CrSign in for TTM
Depreciation36 Cr50 Cr43 Cr65 Cr117 Cr183 Cr315 Cr280 CrSign in for TTM
Profit before tax317 Cr331 Cr394 Cr442 Cr405 Cr431 Cr489 Cr639 CrSign in for TTM
Tax %8.3%10.5%10.0%8.2%7.5%7.9%23.4%-1.4%Sign in for TTM
Net profit291 Cr297 Cr355 Cr406 Cr374 Cr397 Cr375 Cr648 CrSign in for TTM
EPS (₹)₹21.15₹21.61₹26.16₹29.89₹28.10₹28.82₹25.85₹45.33Sign in for TTM
Dividend payout %———20.1%26.7%0.0%26.7%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr
Reserves1,137 Cr1,283 Cr1,563 Cr1,895 Cr2,182 Cr2,573 Cr2,841 Cr3,889 Cr
Borrowings0.29 Cr—0.01 Cr45 Cr830 Cr2,735 Cr2,478 Cr2,310 Cr
Other liabilities385 Cr256 Cr258 Cr319 Cr617 Cr1,092 Cr1,283 Cr1,160 Cr
Total liabilities1,554 Cr1,552 Cr1,835 Cr2,272 Cr3,667 Cr7,049 Cr7,033 Cr7,366 Cr
Fixed assets (net)55 Cr87 Cr78 Cr168 Cr356 Cr505 Cr662 Cr708 Cr
CWIP0.75 Cr0 Cr0 Cr24 Cr21 Cr19 Cr67 Cr171 Cr
Investments356 Cr78 Cr294 Cr520 Cr37 Cr16 Cr67 Cr62 Cr
Loans & advances2 Cr0.94 Cr3 Cr23 Cr4 Cr6 Cr6 Cr53 Cr
Inventories83 Cr69 Cr94 Cr118 Cr131 Cr189 Cr335 Cr437 Cr
Trade receivables84 Cr157 Cr140 Cr161 Cr293 Cr422 Cr459 Cr680 Cr
Cash & bank8 Cr67 Cr37 Cr51 Cr56 Cr94 Cr200 Cr55 Cr
Other assets965 Cr1,092 Cr1,188 Cr1,207 Cr2,769 Cr5,799 Cr5,238 Cr5,199 Cr
Total assets1,554 Cr1,552 Cr1,835 Cr2,272 Cr3,667 Cr7,049 Cr7,033 Cr7,366 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———378 Cr292 Cr486 Cr1,065 Cr538 Cr
Cash from investing———-320 Cr-975 Cr-1,828 Cr-80 Cr-369 Cr
Cash from financing———-45 Cr688 Cr1,380 Cr-881 Cr-314 Cr
Net cash flow———14 Cr5 Cr38 Cr104 Cr-145 Cr
Free cash flow (OCF − Capex)———257 Cr-550 Cr357 Cr910 Cr241 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %29.6%25.7%25.1%23.4%14.1%8.7%12.5%13.4%
ROE %25.3%22.9%22.5%21.3%17.2%12.2%10.8%15.9%
Debtor days3153424363775879
Inventory days517330346365336388441487
Days payable526475376365319551438367
Cash conversion cycle22-92124480-8661199
Debt / equity0.0003—0.00000.020.381.060.870.59
Current ratio1.902.912.803.141.730.910.910.74
Net debt / EBITDA0.000.000.000.001.443.912.242.01

Compare with peers

Loading peers…